Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    BDH Industries Ltd

    Having started off as a fledgling unit in 1935, BDH has grown into a major facility and earned global acclaim. It is today recognised as one of India's leading manufacturers of

  • No Image
    Benova Labs Pvt Ltd

    Benova Labs Pvt Ltd , a Hyderabad based company is engaged in Indian Bulk Drug and intermediates manufacturing . It was established in the year 2012 and the company is focused o

  • No Image
    Bergwerff Organic India Pvt Ltd

    Bergweff Organic India Pvt Ltd is engaged in organic processing, fumigation and sterilisation activities for organic food products (mainly spices like chilli, ginger and turmer

  • No Image
    Beryl Drugs Ltd

    Beryl is as a leader in I.V.Fluids and Small Volume Injectables. Beryl has come a long way and emerged into a global network of pharmaceutical manufacturing ,research and develo

  • No Image
    Beta Drugs Pvt Ltd

    Beta Drugs Pvt Ltd was incorporated on 21 September 2005 is engaged in manufacturing of anticancer drugs and medicinal products and they are located in Solan (Dist. Baddi), Hima